Introduction
Pituicytomas are rare low-grade tumors (World Health Organization grade I) that are derived from pituicytes that are specialized glial cells of the neurohypophysis and infundibulum. Pituicytes are glial cells that function to support the hypothalamic-axons that secrete vasopressin and oxytocin and are comprised of oncocyctic, ependymal, and granular cell types. Their description is primarily limited to case reports, with approximately 80 reported in the literature. However, they closely resemble meningiomas and pituitary adenomas both clinically and radiologically, and therefore their surgical management is similar to these lesions. Surgical treatment, however, is challenging because of the hypervascularity of these lesions. In this chapter, we present a case of a patient with a suprasellar third ventricular pituicytoma.
Chief complaint: seizures
History of present illness
A 49-year-old, right-handed woman with a history of hypertension, anxiety, and depression presented after a seizure. She was working when she had an acute loss of consciousness with generalized tonic-clonic activity. She was taken to the emergency room where imaging was obtained ( Fig. 63.1 ). On further questioning, she complained of progressive confusion and diminished peripheral vision over several months.
Medications : Lithium, hydrochlorothiazide.
Allergies : No known drug allergies.
Past medical and surgical history : Tonsillectomy, hysterectomy.
Family history : No history of intracranial malignancies.
Social history: Accountant, 30 pack per year smoking history, occasional alcohol.
Physical examination : Awake, alert, oriented to person, place, time; Cranial nerves II to XII intact, except mild bitemporal hemianopsia; Moves all extremities with good strength.
Pituitary labs : Prolactin, insulin-like growth factor-1, cortisol, thyroid stimulating hormone/T4 all within normal limits.

Luigi Maria Cavallo, MD, PhD, University of Naples Federico II, Naples, Italy | William T. Curry, MD, Massachusetts General Hospital, Boston, MA, United States | James J. Evans, MD, Tomas Garzon-Muvdi, MD, Thomas Jefferson University, Philadelphia, PA, United States | Tetsuro Sameshima, MD, PhD, Hamamatsu University, Hamamatsu, Shizuoka, Japan | |
---|---|---|---|---|
Preoperative | ||||
Additional tests requested | MRI FIESTA and DTI Neuropsychological assessmentNeuroophthalmology (OCT, visual field) | CT/CT angiography Endocrine evaluation | CT/CT angiography EVD Endocrine evaluation | MRI FIESTA ASL MRI Pituitary hormonal evaluation Neuroophthalmology evaluation |
Surgical approach selected | Right frontal endoscopic transventricular | Right frontal orbital craniotomy with left EVD | Endoscopic endonasal transtubercular, transplanum | Bifrontal basal interhemispheric |
Other teams involved during surgery | None | None | ENT | None |
Anatomic corridor | Right frontal transventricular | Translamina terminalis | Endonasal transtubercular, transplanum | Interhemispheric trans-lamina terminalis |
Goal of surgery | Maximal resection | Maximal resection, resolution of hydrocephalus | Diagnosis, decompression, maximal resection | Total resection |
Perioperative | ||||
Positioning | Supine neutral | Right supine with left 15-degree rotation | Supine without pins | Supine neutral |
Surgical equipment | Surgical navigation EndoscopesNeuroport | Surgical navigation Surgical microscope | Surgical navigation Endoscope Ultrasonic aspirator | Surgical navigation Surgical microscope Ultrasonic aspirator |
Medications | Steroids | Antiepileptics | Steroids | Steroids |
Anatomic considerations | Foramen of Monro, aqueduct, third ventricular floor, infundibular recess, anterior commissure | Optic chiasm, ACA and branches, hypothalamus, pituitary stalk, mammillary bodies, walls of the third ventricle | Pituitary stalk, optic nerves, ICA, ACA, superior hypophyseal arteries | Optic nerves, hypothalamus, infundibulum |
Complications feared with approach chosen | Pituitary dysfunction, hypothalamic disorder fornix injury, CSF leak | Injury to hypothalamus, optic apparatus | Brain retraction | Visual decline, diabetes insipidus, panhypopituitarism |
Intraoperative | ||||
Anesthesia | General | General | General | General |
Skin incision | Linear | Frontotemporal linear | Fascia lata | Bicoronal |
Bone opening | Right frontal mini-craniotomy | Left frontal burr hole, right frontotemporal/orbital roof | Sphenoid bone, sella, tuberculum sellae, planum sphenoidale | Bifrontal |
Brain exposure | Right frontal lobe | Right frontotemporal | Anterior skull base | Bifrontal eccentric to the right |
Method of resection | Right frontal mini-craniotomy based on navigation, small corticectomy, placement of neuroport in right lateral ventricle, bimanual debulking of tumor through foramen of Monro, dissection of tumor from third ventricular walls, third ventriculostomy | Left frontal burr hole, right frontotemporal craniotomy, removal of superior and lateral orbital rims and orbital roof, open dura, subfrontal dissection with identification of olfactory nerve and optic nerves, sharply open cisterns and proximal Sylvian fissure, identify chiasm/ACA/ACOM, dynamic retraction, debulk tumor and follow into third ventricle and dissect from lateral walls, aim for maximal resection | ENT to assist, nasoseptal flap harvest and placed in choanae, lateralization of bilateral middle turbinates, wide right sphenoidotomy, anterior skull base osteotomy of sella/tuberculum/planum using drills and punches, decompress optic nerves proximally, dura opened along midline, sharp dissection to expose anterior tumor, preserve blood vessels supplying optic chiasm and infundibulum, tumor cauterized and opened sharply and debulked followed by extracapsular microdissection, resect as much as possible, fascia lata harvested and button repair of dura is done and reinforced with nasoseptal flap and dural sealant | Bifrontal craniotomy, open dura, sagittal sinus ligation, interhemispheric opening, expose tumor identify key anatomic landmarks (optic nerve, pituitary stalk, hypothalamus), removal of tumor |
Complication avoidance | Use port, avoid forniceal injury, avoid vascular injury inside the ventricle, mindful of floor of third ventricle, third ventriculostomy | EVD, cistern opening, dynamic retraction, follow tumor into third ventricle | Nasoseptal flap and fascia lata, large anterior skull base opening, internal debulking before extracapsular dissection, EVD placement | Bifrontal interhemispheric approach, identify and protect key anatomic landmarks |
Postoperative | ||||
Admission | ICU | ICU | ICU | ICU |
Postoperative complications feared | Hypothalamic dysfunction, diabetes insipidus, hypopituitarism, visual decline | Cognitive decline, endocrine dysfunction, visual decline | CSF leak, hypopituitarism | Visual decline, hormonal dysfunction |
Follow-up testing | Head CT immediately after surgery MRI within 48 hours after surgery Pituitary hormone analysis Visual field assessment | MRI 6 weeks after surgery if GTR, or MRI prior to discharge if STR | MRI 3 months after surgery Pituitary panel after surgery Sodium/SG if UOP >250 cc/hr for 2 hours | Hormonal evaluation CT immediately after and 1 day after surgery MRI 7 days after surgery |
Follow-up visits | 1 month after surgery with neuropsychology, endocrinology, and visual field testing | 6 weeks after surgery with neurosurgery 1 month after surgery with endocrinology | 1 week after surgery with ENT and neurosurgery | 3 months after surgery |
Adjuvant therapies recommended | Observation, repeat surgery or radiation therapy with recurrence | Observation, repeat surgery or radiation therapy with recurrence | Observation and possible radiotherapy with growth | Observation and repeat surgery with recurrence |

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree


